Proto labs inc (PRLB)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Operating activities
Net income

63,655

76,588

51,778

42,707

46,514

41,635

35,277

24,025

17,972

10,951

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

30,864

26,754

18,474

17,485

14,126

11,138

7,569

6,080

4,264

3,483

Stock-based compensation expense

10,781

10,928

8,558

6,775

6,082

4,809

3,461

3,039

1,130

331

Deferred taxes

6,106

11,936

1,174

2,780

2,837

-1,875

467

-583

2,230

561

Excess tax benefit from stock-based compensation

-

-

-

-

-

4,470

9,873

6,218

657

-

Loss on impairment of assets

0

0

513

455

0

0

-

-

-

773

Gain on sale of businesses

0

671

0

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-

-110

-154

10

-26

Gain on acquisition

-

-

-

-

344

0

0

-

-

-

Amortization of held-to-maturity securities

-5

-374

-1,063

-1,173

-1,234

-1,517

-1,468

-369

-

-

Other

-391

619

153

1,541

0

0

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-1,848

6,098

9,933

-900

11,371

5,304

2,470

4,372

3,457

2,993

Inventories

-60

189

985

-136

2,097

896

579

829

2,195

537

Prepaid expenses and other

-545

2,098

691

1,312

2,047

-107

-1,630

1,887

591

801

Income taxes

6,555

-6,652

1,646

8,207

-2,310

9,373

8,845

4,314

37

-104

Accounts payable

-719

1,942

3,176

-1,116

5,781

1,435

1,651

306

1,545

1,148

Accrued liabilities and other

-4,039

10,734

7,128

850

5,691

-259

885

1,277

3,267

1,174

Net cash provided by operating activities

116,052

122,929

81,748

77,499

64,096

57,210

48,441

25,675

23,535

14,012

Investing activities
Proceeds from sale of property and equipment

-

-

-

-

-

-

-

-

-

30

Purchases of property, equipment and other capital assets

62,230

87,104

32,635

33,616

44,362

43,507

18,753

17,397

19,003

7,069

Cash used for acquisitions, net of cash acquired

0

90

110,533

-

5,032

33,864

0

-

-

-

Proceeds from sale of businesses

0

284

0

-

-

-

-

-

-

-

Purchases of other assets and investments

4,000

126

8,742

-

0

-

-

-

-

-

Purchases of marketable securities

46,403

41,384

20,037

89,315

66,393

60,186

106,298

84,588

-

1,504

Proceeds from maturities of marketable securities

68,330

65,139

47,972

62,176

52,193

74,058

66,570

22,368

500

2,502

Net cash (used in) provided by investing activities

-44,303

-63,281

-123,975

-60,755

-63,594

-63,499

-58,481

-79,617

-18,503

-6,041

Financing activities
Proceeds from initial public offering, net of offering costs

-

-

-

-

-

-

-

71,530

-

-

Proceeds from follow-on offering, net of offering costs

-

-

-

-

-

-

-

2,451

-

-

Payments on debt

0

5,000

0

-

152

1,054

258

388

4,049

4,702

Proceeds from issuance of debt

0

0

5,000

-

0

-

-

-

-

417

Proceeds from exercises of stock options

4,391

8,935

8,602

5,715

6,251

4,820

6,496

2,975

547

56

Purchases of shares withheld for tax obligations

2,487

2,144

0

-

-

-

-

-

-

-

Acquisition-related contingent consideration

-

-

-

400

1,400

1,200

0

-

-

-

Repurchases of common stock

33,521

12,229

4,410

-

0

-

-

-

-

-

Excess tax benefit from stock-based compensation

-

-

-

-

-

4,470

9,873

6,218

657

-

Net cash used in financing activities

-31,617

-10,438

9,192

5,315

4,699

7,036

16,111

82,786

-2,845

-4,229

Effect of exchange rate changes on cash and cash equivalents

47

-871

947

-917

-877

-457

209

-220

-153

-344

Net (decrease) increase in cash and cash equivalents

40,179

48,339

-32,088

21,142

4,324

290

6,280

28,624

2,034

3,398

Supplemental cash flow disclosure
Cash paid for interest

14

39

19

1

5

19

35

63

140

256

Cash paid for taxes

4,002

9,966

19,113

9,802

20,330

11,549

6,593

7,990

5,358

4,663